Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00101751 · ClinicalTrials.gov registry record · Phase 4
INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study
A Phase 4 study of Diabetes Mellitus, Type 2 and Diabetes, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- Phase 4
- Development phase
- 4,877
- Enrollment target
- 1
- Study location
NCT00101751: Completed Phase 4 study of Diabetes Mellitus, Type 2 and Diabetes, sponsored by Novo Nordisk A/S.
NCT00101751 is a Phase 4 study of Diabetes Mellitus, Type 2 and Diabetes that has completed, run by Novo Nordisk A/S. The registered enrollment target is 4,877 participants, roughly in line with the 4,471-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00101751, a Phase 4 study of Diabetes Mellitus, Type 2 and Diabetes, has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 4,877 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial is conducted in the United States of America (USA). The purpose of this study is to compare the effectiveness and safety of a biphasic insulin aspart standard titration regimen when coupled with dietary intervention to standard titration without dietary intervention.
Conditions Studied
Interventions
- DRUG biphasic insulin aspart
- BEHAVIORAL dietary regimen
Study Locations (1)
New Jersey
- Novo Nordisk Clinical Trial Call Center - Princeton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,877 participants |
| Start Date | 2004-10 |
| Est. Completion | 2006-06 |
| Phase | Phase 4 |
What the finished NCT00101751 record still lists
NCT00101751 is an interventional study that assigns participants to a tested intervention. Its 4,877 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 4,471-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target.
The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which biphasic insulin aspart is the first listed.
NCT00101751 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT00101751 about?
NCT00101751 is a clinical study titled "INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study". This trial is conducted in the United States of America (USA). The purpose of this study is to compare the effectiveness and safety of a biphasic insulin aspart standard titration regimen when coupled with dietary intervention to standard titration without dietary intervention.
What is the current status of trial NCT00101751?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 4,877 participants. The study started on 2004-10. Estimated completion is 2006-06.
What conditions does trial NCT00101751 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Diabetes.
What interventions are being tested in trial NCT00101751?
The interventions under investigation include: biphasic insulin aspart (DRUG), dietary regimen (BEHAVIORAL).
Who is sponsoring clinical trial NCT00101751?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00101751 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00101751's enrollment target sits among peer trials
4,877 16th of 348 higher than 333 of 348 other Diabetes Mellitus, Type 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
RECRUITING · Phase 4
-
Knee Osteoarthritis Treatment With Zilretta vs. Kenalog in the Context of Type II Diabetes
RECRUITING · Phase 4
-
Effect of Continuing Versus Holding Metformin During Hospitalizations.
RECRUITING · Phase 4
-
Surgical or Medical Treatment
ACTIVE NOT RECRUITING · Phase 4
-
Afrezza® Dosing Optimization Study
COMPLETED · Phase 4
-
Effect of Thiazolidinedione Treatment Vascular Risk Markers
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05252754 · 4,874 participants · Phase 3
Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
- NCT05929976 · 4,900 participants
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
- NCT01719055 · 4,800 participants
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
- NCT05485675 · 4,800 participants · NA
Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia